Key takeaways
Novolin N (insulin NPH) and Janumet (sitagliptin/metformin) are both used to manage diabetes, but they work in different ways and have different uses. Novolin N is an intermediate-acting insulin that helps control blood sugar levels in people with Type 1 or Type 2 diabetes. It is injected under the skin once or twice a day and is available as a prescription and over the counter. On the other hand, Janumet is a combination of sitagliptin, a DPP-4 inhibitor, and metformin, and is used only for Type 2 diabetes. Janumet requires a prescription and is taken orally with meals, either as immediate-release tablets twice daily or extended-release tablets (Janumet XR) once daily. Novolin N can cause low blood sugar and weight gain, while Janumet is less likely to cause these issues but can lead to side effects like diarrhea and headache. Additionally, Janumet is not suitable for people with severe kidney problems, whereas Novolin N can be used by those with liver or kidney issues.
